CDC Recommends Merck’s CAPVAXIVE™ for Adult Pneumococcal Vaccination
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) has unanimously recommended CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
ObjectiveHealth, QualDerm Expand Partnership to Enhance Patient Care Options
ObjectiveHealth, a Nashville-based integrated research and technology platform company, has announced an expansion of its partnership with QualDerm Partners, LLC, a leading dermatology and skin care management services organization also based in Nashville. This collaboration aims to integrate clinical research…
Genoks and Velsera Partner to Transform Cancer Diagnostics in Turkey
Genoks, a leading genomics healthcare company based in Turkey, has partnered with Velsera, a global healthcare technology firm specializing in a universal software platform connecting clinical care with discovery. Together, they aim to advance cancer diagnostics and treatment not only…
Brenus Pharma Earns Global Cancer Stream Accreditation 2023/2024 from Creative Destruction Lab & NA Universities
Last year, Brenus Pharma was chosen to join CDL Cancer, a global mentoring program supporting highly scalable, science-driven companies advancing cancer treatments. Distinguished by its innovative STC platform focused on developing next-generation therapeutic cancer vaccines, Brenus impressed during a rigorous…
Augustine Therapeutics Secures EUR 17M for Clinical Development in Neurological Diseases
Augustine Therapeutics, a pioneering biotech firm dedicated to innovative therapies for neurodegenerative and cardiometabolic diseases, has successfully secured EUR 17 million (USD 18.5 million) in the initial closing of its Series A funding round. The financing was led by Asabys…
ARC Fertility Wins Spring 2024 Digital Health Award for Mobile App
“This award is a testament to our team’s dedication and innovation in developing the FertilityNow app, which offers personalized, convenient, and effective support to make fertility care more accessible and efficient,” said David Adamson, MD, founder and CEO of ARC…
PQE Group Launches AI & Data Analytics Division for Life Sciences
PQE Group, a leading consultancy in the Life Science sector, has launched its new Regulated Artificial Intelligence & Data Analytics division, marking a significant advancement since the introduction of AI-based tools in industrial settings. With over 2000 employees, the Italian…
Swift Medical Appoints New CEO and CTO to Leadership Team
Swift Medical, a leading digital health technology company specializing in enhancing clinical outcomes in chronic and acute wound care, is pleased to announce the appointment of Dwayne Sansone as Chief Executive Officer and Stratos Davlos as Chief Technology Officer. These…
Greenspace Health Partners Teams Up with Behavioral Health Innovations for Digital Assessments
Greenspace Health and Behavioral Health Innovations (BHI) have announced a strategic partnership aimed at enhancing access to BHI’s evidence-based assessments through digital platforms. This collaboration seeks to streamline the administration of assessments such as the UCLA PTSD Reaction Index, crucial…
TVM Capital Healthcare Invests $35M in Boston Oncology Arabia
TVM Capital Healthcare has announced a USD 35 million investment in Boston Oncology Arabia, a bio-generic drugs manufacturer based in Saudi Arabia. Headquartered in Riyadh with a production facility in Sudair Industrial City, Boston Oncology Arabia focuses on locally developing…
Technology Holdings advises Design + Industry on sale to Capgemini
Technology Holdings, a global investment bank with offices in North America, Europe, and Asia-Pacific, has acted as the exclusive financial advisor to Design + Industry in its strategic sale to Capgemini. Design + Industry, founded in 1987 and based in…
Flow Cytometry & Extracellular Vesicles 2024 Conference: Laguna Hills, USA – Nov 18-20
ResearchAndMarkets.com is pleased to announce the addition of the “Innovations in Flow Cytometry & Extracellular Vesicles 2024” conference to its offerings. Bringing together researchers and industry participants from academia and industry alike, this established event will focus on the latest…